Skip navigation

Daiichi Sankyo Co. Ltd.

Pharmaceuticals
Japan
2016 Revenue (US$ Millions)$8,166
Revenue Growth (%)-3.18%
Net Income (US$ Millions)$457
Earnings Per Share (US$)$0.68
EPS Growth Rate (%)-33.31%
Profit Margin5.60%
Total Equity (US$ Millions)$10,054
Return on Equity (%)4.34%
Long Term Debt (US$ Millions)$2,399
Debt To Equity Ratio (%)0.24%
Total Assets (US$ Millions)$16,373
Current Assets (US$ Millions)$10,241
Current Liabilities (US$ Millions)$2,794
Cost of Goods Sold (US$ Millions)$2,987
Inventory Turnover2.35